Description
12 genes Mutations, Fusion, PD-L1 22C3.
Tissue, NA, Fasting or Non Fasting: As suggested by doctor
Sample Required:
FFPE lung tumour tissue block OR fresh tissue in DCGL Preservative Solution at 2–8°C; tumour content >10%.
Test Time:
Biopsy-dependent. 8–12 working days.
Test Normal Range:
No fixed normal range.
What is the Test?
An NGS + IHC panel evaluating **12 genes** for mutations and fusions, including **PD-L1 (22C3)** expression for immunotherapy planning.
Test Procedure:
Tumour tissue undergoes NGS sequencing along with PD-L1 IHC staining.
When to Take the Test:
When genomic profiling and PD-L1 status are required for therapy selection.
Who Should Take This Test:
Patients with lung cancer being evaluated for targeted therapy or immunotherapy.
Precautions for Exceptional Cases (Pregnancy, etc.):
Ensure tissue fixation quality; disclose pregnancy before biopsy.
